Navigation Links
Skyline Diagnostics and Clavis Pharma to Collaborate on Patient Selection Biomarker Discovery for Leukemia Drug elacytarabine
Date:9/6/2011

ROTTERDAM, The Netherlands, September 6, 2011 /PRNewswire/ --

The Dutch biotech company Skyline Diagnostics B.V. (Skyline) and the Norwegian drug development company Clavis Pharma ASA (Clavis) disclosed signing a research agreement. Under this agreement, Skyline will investigate gene expression biomarkers for selection of individual Acute Myeloid Leukemia (AML) patients that may benefit from a new AML drug in development at Clavis. This drug, elacytarabine, is a novel elaidic acid derivative of cytarabine and currently undergoing the CLAVELA phase III study for treatment of patients with relapsed/refractory AML.

"For Clavis and for elacytarabine this is an important collaboration. Skyline Diagnostics's expertise will be instrumental in searching for gene expression patterns that can be utilized in the further biomarker program of elacytarabine," said Athos Gianella-Borradori, CMO of Clavis Pharma, "this genomic approach adds to our currently ongoing patient selection based on  protein markers and will deepen our insights into the potential for precise and highly effective personalized medicines. It is our goal and vision that this collaboration with the experts of Skyline will bring better therapies to the many patients suffering from difficult-to-treat leukemia."

"After the successful launch of the AMLprofiler in Europe, we are pleased to further strengthen our companion diagnostics activities," said Henk Viëtor, CEO of Skyline.

"Pharma companies are recognizing the value of companion diagnostics in positioning their drugs. By applying our bioinformatics engine, product development and regulatory experience, we can add substantial value to the process of drug development. We look forward working together with Clavis Pharma on this exciting personalized medicine opportunity."

About Skyline Diagnostics B.V.

Skyline Diagnostics develops and markets array-based diagnostic tests for personalized medicine. Skyline's
'/>"/>

SOURCE Skyline Diagnostics B.V.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
2. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
3. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
4. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
5. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
6. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
7. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
8. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
9. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
10. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
11. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Vasomedical, Inc. (OTC BB: ... the design, manufacture and sale of medical devices and in ... Dr. Jun Ma , President and CEO ... LLP MicroCap Conference on Thursday, May 30, 2013 in ... Hotel. The Company,s presentation is scheduled to ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
(Date:5/21/2013)... 2013 Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Martin Mulroy , chief commercial ... & Veterinary Conference on Wednesday, May 29, 2013 at ... Le Parker Meridien Hotel in New York ... Abaxis develops, manufactures, markets and sells portable blood analysis ...
Breaking Medicine Technology:Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
... NEW HAVEN, Conn., Aug. 5 Rib-X ... company focused on the,discovery and development of ... announced today that company,representatives are giving three ... Research Conference on Medicinal Chemistry, August 3-8, ...
... Aug. 5 Nexgen Spine, a leading,developer of ... disc disease, announced today that it has received ... Disc in the European,Union., "We are delighted ... mark approval," said Alastair Clemow, Ph.D., President and ...
Cached Medicine Technology:Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 2Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences 3Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
(Date:5/21/2013)... Journal of the Pediatric Infectious Diseases Society ... issue, which includes a consensus statement of the ... It establishes standardized definitions, measurements, and other key ... the first step as the group of international ... and resources that can improve children,s access to ...
(Date:5/21/2013)... 2013 Children with autism showed significant improvement after ... everyday items such as scents, spoons and sponges, according ... treatment known as environmental enrichment led to notable gains ... 12. Results appear online in Behavioral Neuroscience . ... assigned 28 boys to one of two groups, balanced ...
(Date:5/21/2013)... Human Reproduction & Embryology) is now the world,s leading ... expected this year, presenting a wealth of new research ... public interest. Reports from proceedings of the ESHRE congress ... , This year,s event will be held at the ... July. , The scientific programme for this year,s event ...
(Date:5/21/2013)... 21, 2013 Children using the ... Inc., experience audiological results comparable to the traditionally ... fewer complications, according to a new study. , ... Sophono’s abutment-free technology performs just as well as ... many fewer complications,” says Jim Kasic, president and ...
(Date:5/21/2013)... Adeptia, a leading provider of innovative cloud and ... the featured company in an impact report written and ... Bets on Converged Cloud Integration and Process-Orchestration Suites,” offers ... pricing, customers and competition. , “For organizations ... and process orchestration, especially when price, ease of use ...
Breaking Medicine News(10 mins):Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 2Health News:JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children 3Health News:Enrichment therapy effective among children with autism, UCI study finds 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Adeptia Featured in Recent 451 Research Impact Report 2
... Revenue, Net ... MICROS Systems, Inc.,(Nasdaq: MCRS ), a leading supplier of information ... its,fiscal 2008 first quarter ended September 30, 2007. FINANCIAL HIGHLIGHTS, ... of $42.8 million, or 24.6%, over the ...
... wrigglers, orientation , THURSDAY, Oct. 25 (HealthDay News) -- ... worms called nematodes, say scientists who genetically manipulated some ... same sex. , The finding might give some insight ... conclusions are narrow in that they are about worms ...
... Partners with Osiris on a Phase II Trial to ... Diabetes , New York, NY October ... today a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to ... immunomodulatory cell therapy product, to preserve and regenerate insulin-producing ...
... Result of Alliance with Dr. James Levine of ... Steelcase Inc. (NYSE: SCS ),a global ... workstation with an integrated treadmill, at its New,York ... from the,FitWork(TM) category of products designed to bring ...
... In its first-ever,single-topic special issue, the Harvard Heart ... advice aimed at unscrambling the mixed,messages about what ... nutrition, its recommendations include:, -- You can,t ... exercise,fruits and vegetables are the closest thing we ...
... snacking and mobile devices more appetizing than sit-down ... increasingly are,attached to portable devices such as laptops, ... eat-and-run mode. According to a,recent survey(1) conducted for ... ), nearly one in three Americans ages 18-34,has ...
Cached Medicine News:Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Worm Study Points to Sexuality's Origins 2Health News:JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes 2Health News:Steelcase Unveils the Walkstation to Bring Healthy Habits to The Workplace 2Health News:Steelcase Unveils the Walkstation to Bring Healthy Habits to The Workplace 3Health News:All About Heart-Healthy Eating: The Harvard Heart Letter Devotes an Issue to Nutrition 2Health News:ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table 2Health News:ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: